期刊文献+

母婴疾病防治领域的新兴医学科技进展

Advances in emerging medical technologies in the field of prevention and treatment of maternal and infant diseases
原文传递
导出
摘要 提高妇幼健康水平作为建设健康中国的重要任务之一,需要加强和推动医药健康科技创新,为保障和改善妇幼健康提供有力的科技支撑。因此,本文对基因诊断与基因治疗技术、多组学技术、干细胞技术、组织工程技术等前沿生物技术以及机器人技术、大数据与人工智能技术在母婴健康医学科技领域的发展现状和未来趋势作一概述,对新兴技术在母婴疾病防治中面临的伦理挑战进行了分析,并提出了母婴疾病防治的重点发展方向,以期为从事母婴疾病防治领域科技创新和技术服务的专业人员提供参考。 As one of the important tasks of building the Healthy China,improving maternal and child health needs to strengthen and promote medical and health scientific and technological innovations,so as to provide strong scientific and technological support for ensuring and improving maternal and child health.Therefore,this paper summarizes the development status and future trend of cutting-edge biotechnology such as gene diagnosis and gene therapy,multiomics technology,stem cell technology and tissue engineering technology,as well as robot technology,big data and artificial intelligence technology in the field of maternal and infant health medical science and technology,and analyzes the ethical challenges faced by emerging technologies in the prevention and treatment of maternal and infant diseases.It also puts forward the key development direction of maternal and infant disease prevention and control,in order to provide reference for professionals engaged in scientific and technological innovation and technical services in the field of maternal and infant disease prevention and control.
作者 乔杰 Qiao Jie(Department of Obstetrics and Gynecology,Peking University Third Hospital,National Clinical Research Center for Obstetrics and Gynecology,Beijing 100191,China)
出处 《中华生殖与避孕杂志》 CSCD 北大核心 2022年第1期1-8,共8页 Chinese Journal of Reproduction and Contraception
基金 北京市科学技术委员会(Z191100006619073) 中国工程院咨询研究项目(2020-XZ-22)。
关键词 母婴疾病 新兴医学科技 伦理 Maternal and infant diseases Emerging medical technologies Ethic
  • 相关文献

参考文献5

二级参考文献27

  • 1Takahashi K, Yamanaka S. Induction of pluripotent stem ceils from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126 (4):663-676.
  • 2Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem ceils from adult human fibroblasts by defined factors. Cell, 2007, 131(5) : 861-872.
  • 3Yu J, Vodyanik M A, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic ceils. Science, 2007, 318 (5858) : 1917-1920.
  • 4Okita K, Iehisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem ceils. Nature, 2007, 448 (7151) :313- 317.
  • 5Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell, 2008, 132 (4) :567-582.
  • 6Cheng J, Dutra A, Takesono A, Garrett-Beal L, Schwartzberg P L. Improved generation of C57BL/6J mouse embryonic stem cells in a defined serum-free media. Genesis, 2004, 39 (2) : 100-104.
  • 7Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell, 2007, 1 (3) :245-247.
  • 8Cyranoski I). Mice made from induced stem cells. Nature, 2009, 460 (7255) :560.
  • 9Zhao X Y, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461, 86-90.
  • 10Rochow N, Chan EC, Wu WI, et al. Artificial placenta - Lung assist devices for term and preterm newborns with respiratory fail- ure [J]. Int J Artif Organs, 2013, 36 (6): 377-391.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部